Differential Expression of Peroxiredoxins in Prostate Cancer: Consistent Upregulation of PRDX3 and PRDX4

BACKGROUND: The peroxiredoxins (PRDXs) are emerging as regulators of antioxidant defense, apoptosis, and therapy resistance in cancer. Because their significance in prostate cancer (PCa) is unclear, we investigated their expression and clinical associations in PCa. METHODS: Transcript expression of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Basu, Anamika, Banerjee, Hiya, Rojas, Heather, Martinez, Shannalee R., Roy, Sourav, Jia, Zhenyu, Lilly, Michael B., De León, Marino, Casiano, Carlos A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107902/
https://ncbi.nlm.nih.gov/pubmed/21031435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21292
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares